Mesenteric artery complications during angioplasty and stent placement for atherosclerotic chronic mesenteric ischemia
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Objective The purpose of this study was to describe the incidence, management, and outcomes of mesenteric artery complications (MACs) during angioplasty and stent placement (MAS) for chronic mesenteric ischemia (CMI). Methods We retrospectively reviewed the clinical data of 156 patients treated with 173 MAS for CMI (1998–2010). MACs were defined as procedure-related mesenteric artery dissection, stent dislodgement, embolization, thrombosis, or perforation. End points were procedure-related morbidity and death. Results There were 113 women and 43 men (mean age, 73 ± 14 years). Eleven patients (7%) developed 14 MACs, including distal mesenteric embolization in six, branch perforation in three, dissection in two, stent dislodgement in two, and stent thrombosis in one. Five patients required adjunctive endovascular procedures, including in two patients each, catheter-directed thrombolysis or aspiration, retrieval of dislodged stents, and placement of additional stents for dissection. Five patients (45%) required conversion to open repair: two required evacuation of mesenteric hematoma, two required mesenteric revascularization, and one required bowel resection. There were four early deaths (2.5%) due to mesenteric embolization or myocardial infarction in two patients each. Patients with MACs had higher rates of mortality (18% vs 1.5%) and morbidity (64% vs 19%; P <.05) and a longer hospital length of stay (6.3 ± 4.2 vs 1.6 ± 1.2 days) than those without MACs. Periprocedural use of antiplatelet therapy was associated with lower risk of distal embolization or vessel thrombosis (odds ratio, 0.2; 95% confidence interval, 0.06–0.90). Patients treated by a large-profile system had a trend toward more MACs (odds ratio, 1.8; 95% confidence interval, 0.7–26.5; P = .07). Conclusions MACs occurred in 7% of patients who underwent MAS for CMI and resulted in higher mortality, morbidity, and longer hospital length of stay. Use of antiplatelet therapy reduced the risk of distal embolization or vessel thrombosis. There was a trend toward more MACs in patients who underwent interventions performed with a large-profile system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identifying and grading factors that modify the outcome of endovascular aortic aneurysm repair
Chaikof, E. L., Fillinger, M. F., Matsumura, J. S., Rutherford, R. B., White, G. H., Blankensteijn, J. D., Bernhard, V. M., Harris, P. L., Kent, K. C., May, J., et al. (2002) · Journal of Vascular Surgery · doi:10.1067/mva.2002.123991 · Cited by 629
Mesenteric revascularization: management and outcomes in the United States, 1988-2006
Schermerhorn, M. L., Giles, K. A., Hamdan, A. D., Wyers, M. C., & Pomposelli, F. B. (2009) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2009.03.004 · Cited by 311
Atkins, M. D., Kwolek, C. J., LaMuraglia, G. M., Brewster, D. C., Chung, T. K., & Cambria, R. P. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2007.01.067 · Cited by 217 · cited 1×
“018-inch 75 (48) Femoral + large profile 67 (43) + small profile 39 (25) Brachial + small profile 36 (23) + large profile 14 (9) Residual stenosis Absent 132 (85) <30% 16 (10) >30% 8 (5) PTA, Percutaneous transluminal angioplasty; SD, standard deviation.”
Open versus endovascular revascularization for chronic mesenteric ischemia: Risk-stratified outcomes
Oderich, G. S., Bower, T. C., Sullivan, T. M., Bjarnason, H., Cha, S., & Gloviczki, P. (2009) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2009.02.006 · Cited by 186
Self-citationMatsumoto, A. H., Angle, J. F., Spinosa, D. J., Hagspiel, K. D., Cage, D. L., Leung, D. A., Kern, J. A., Tribble, C. G., & Kron, I. L. (2002) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(01)01062-6 · Cited by 159
Mesenteric stenting for chronic mesenteric ischemia
Brown, D. J., Schermerhorn, M. L., Powell, R. J., Fillinger, M. F., Rzucidlo, E. M., Walsh, D. B., Wyers, M. C., Zwolak, R. M., & Cronenwett, J. L. (2005) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2005.03.054 · Cited by 151
Endovascular Treatment of Chronic Arterial Mesenteric Ischemia: A changing perspective?
Gibbons, C. P., & Roberts, D. E. (2010) · Seminars in Vascular Surgery · doi:10.1053/j.semvascsurg.2009.12.006 · Cited by 25
Cited by
Editor's Choice – Management of the Diseases of Mesenteric Arteries and Veins
Björck, M., Koelemay, M., Acosta, S., Bastos Goncalves, F., Kölbel, T., Kolkman, J. J., Lees, T., Lefevre, J. H., Menyhei, G., Oderich, G., et al. (2017) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2017.01.010 · Cited by 658
Self-citationChronic mesenteric ischemia: Clinical practice guidelines from the Society for Vascular Surgery
Huber, T. S., Björck, M., Chandra, A., Clouse, W. D., Dalsing, M. C., Oderich, G. S., Smeds, M. R., & Murad, M. H. (2021) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2020.10.029 · Cited by 152
Self-citationOderich, G. S., Erdoes, L. S., LeSar, C., Mendes, B. C., Gloviczki, P., Cha, S., Duncan, A. A., & Bower, T. C. (2013) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2013.05.013 · Cited by 149
Self-citationThe Ongoing Challenge of Acute Mesenteric Ischemia
Luther, B., Mamopoulos, A., Lehmann, C., & Klar, E. (2018) · Visceral Medicine · doi:10.1159/000490318 · Cited by 93
Chronic Mesenteric Ischemia: 20 Year Experience of Open Surgical Treatment
Lejay, A., Georg, Y., Tartaglia, E., Creton, O., Lucereau, B., Thaveau, F., Geny, B., & Chakfe, N. (2015) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2015.01.004 · Cited by 43
Metadata
- Authors
- Oderich, G. S., Tallarita, T., Gloviczki, P., Duncan, A. A., Kalra, M., Misra, S., Cha, S., & Bower, T. C.
- Venue
- Journal of Vascular Surgery
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 55
- Issue
- 4
- Pages
- 1063-1071
- ISSN
- 0741-5214 (ISSN-L)
- OpenAlex
- W1989225884
- Cited by
- 103
- References
- 7
- FWCI
- 6.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.